EverHint – Pullback Standard – Top 4 Signals for Jun 24, 2026

Excerpt: 4 signals. Healthcare leads (2). price range $84-$747. 1 with insider selling.

What This Signal Is

Standard pullback setup - stocks that dipped below MA21 and reclaimed it. Indicates potential bounce/continuation after healthy pullback. Lower-risk entries in established uptrends.

Entry Criteria:

• Dipped below MA21
• Reclaimed MA21 on increased volume
• Volume surge above average
• Minimum ADV: $25M+
• Earnings buffer: 7 days

Holding period: 1-4 weeks | Risk level: Medium-High

Market Context

The major indices are sending mixed signals heading into this session, with the Dow Jones outperforming while the Nasdaq lags — a classic pattern suggesting rotation away from growth and technology toward more defensive or value-oriented names. The S&P 500 is essentially flat, reflecting a market in a holding pattern rather than a decisive directional move. For momentum swing strategies, this kind of divergence can be a double-edged sword: it creates opportunities in sectors showing relative strength, but also increases the risk of false breakouts in broader index-correlated plays.

Volatility, as measured by the VIX at 19.51, sits in a moderately elevated range — not at panic levels, but meaningfully above the complacency zone below 15. This level of implied volatility tends to widen intraday price swings, which can amplify both gains and losses on momentum-based entries. Traders should expect choppier price action and consider sizing positions accordingly, as stop levels may need to be wider to avoid being shaken out by normal intraday noise.

The concentration of signals in Healthcare is consistent with the broader rotation narrative visible in today's index performance. Healthcare tends to attract capital during periods of uncertainty or when growth sentiment softens, acting as a defensive anchor in portfolios. With the Nasdaq underperforming and risk appetite appearing cautious, momentum swing setups in Healthcare may benefit from genuine sector tailwinds rather than pure speculative momentum — generally a more sustainable setup for this strategy type.

📊 Signals (4 of 4 total)

Ranked by composite momentum score

Field Notes

Sector concentration: Healthcare (2), Industrials (1), Consumer Defensive (1)

Insider selling: GH (Guardant Health, Inc., -$1,578,256)

Data coverage: 25.0% insider, 25.0% congressional, 0.0% earnings, 25.0% news

Peer Analysis

IESC (IES Holdings, Inc.): Leads 5 peers: PRIM ($92.69), DY ($483.48), FLR ($53.17), TTEK ($28.58), AWI ($157.70)

NVS (Novartis AG): Leads 5 peers: AZN ($183.02), GSK ($51.09), BMY ($55.00), SNY ($41.33), MRK ($120.65)

BUD (Anheuser-Busch InBev SA/NV): Leads 5 peers: SAM ($182.84), ABEV ($3.13), TAP ($40.53), FMX ($123.08), CCU ($11.14)

GH (Guardant Health, Inc.): Leads 5 peers: ICLR ($158.17), RVTY ($105.63), ASND ($238.01), VTRS ($15.93), QGEN ($38.73)

Congressional Activity

GH (Guardant Health, Inc.) 🟢 Bullish

• 1 purchase by 1 member

Recent Headlines

BUD (Anheuser-Busch InBev SA/NV)

• How 770 Shares of This Beer Giant Yield About $100 a Year
• Here's Why Anheuser-Busch Inbev (BUD) is a Strong Value Stock
• Why Diageo, Heineken and Anheuser-Busch are battling falling alcohol demand
• AB InBev's Premiumization and Digital Transformation Drive Growth
• Boomers Need the Safest Dividend Stocks. We Asked Claude and Found 5 That Yield 5% or More
• Anheuser‑Busch Launches the "ComBar" to Celebrate American Farmers and U.S. Farmed Beer

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/

📢 Support the project by liking, sharing, or subscribing — it helps more readers discover these signals.